Clinical Trial Update: Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

View source ↗

Summary

A completed clinical trial update exploring the mechanisms behind cutaneous neurofibroma formation in neurofibromatosis type 1 using a translational approach.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Neurofibroma
• Neurofibromatosis Type
• Plexiform Neurofibroma

Snippet

Sponsor: Corewell Health West | Conditions: Cutaneous Neurofibromas, Neurofibromatosis Type 1 | Status: COMPLETED